Thoracic aortic aneurysms
Revisado por pares por Dr Doug McKechnie, MRCGPÚltima actualización por Dr Colin Tidy, MRCGPLast updated 12 Jun 2023
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
- Add to preferred sources on Google
Profesionales Médicos
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Aneurisma aórtico abdominal article more useful, or one of our other artículos de salud.
En este artículo:
Vea también el separado Abdominal Aortic Aneurysms, Ruptured Aortic Aneurysm y Aortic Dissection articles.
Continúa leyendo abajo
What is a thoracic aortic aneurysm?1
An aneurysm is a permanent and irreversible dilatation of a blood vessel by ≥50% of its normal expected diameter. Aortic aneurysms are classified as abdominal (the majority) or thoracic. The normal size of the mid-descending thoracic aorta is 26-28 mm. A 'true aneurysm' involves dilatation of all three layers of the arterial wall.
Thoracic aortic aneurysms (TAAs) may affect various parts of the thoracic aorta:
Ascending aorta - between aortic annulus and innominate artery (these may cause aortic valve regurgitation if they are proximal enough).
Aortic arch.
Descending aorta - from the left subclavian artery distally.
Thoraco-abdominal aorta - distal thoracic aorta and abdominal aorta.
How common are thoracic aortic aneurysms?(Epidemiology)2
Volver al contenidoThe true incidence and mortality rate of TAAs is not known.
A population-based study reported an incidence of 5.9 new aneurysms per 100,000 person-years in a Midwestern community over a 30-year period with median ages of 65 years for men and 77 years for women.
51% of aneurysms were in the ascending aorta, 11% in the arch and 38% in the descending thoracic aorta. Prevalence may be at least 3-4 % of those aged >65 years and is probably increasing.3 4
Continúa leyendo abajo
What causes a thoracic aortic aneurysm? (Aetiology)5
Volver al contenidoPatogénesis3 4
The pathogenesis of TAA is complex and probably involves inflammation, proteolysis and reduced survival of smooth muscle cells in the aortic wall. There is probably an imbalance of proteolytic enzymes versus their inhibitors. Once the aorta reaches a critical diameter (about 6 cm in the ascending aorta and 7 cm in the descending aorta), it loses all distensibility so that a rise in blood pressure to around 200 mm Hg (as can occur physiologically during stress or exertion) can exceed the arterial wall strength and may trigger dissection or rupture.
Causas3
Genetic - there is a strong genetic component.4 In some families, there appears to be an autosomal dominant trait causing TAA.6 7
Certain connective tissue disorders:
Loeys-Dietz syndrome (which partly resembles Marfan's syndrome).8
Infections:
Mycotic aneurysm.9
Aortitis - eg, from giant cell arteritis, rheumatoid arthritis, Behçet's disease, Takayasu's arteritis or retroperitoneal fibrosis.
Aortic dissection may be a cause (or a result) of TAA.
Pregnancy is a risk factor for aneurysm dissection.
Trauma.
Weightlifting, cocaine and amphetamine use may be involved in causing TAA and/or aortic dissection - perhaps because of the large rises in blood pressure which occur during these activities.
Factores de riesgo3 11 12
These factors probably result in an increased rate of growth of aneurysms:3 13
Hipertensión is the major risk factor for thoracic aortic disease.14
Edad avanzada.
Fumar.
Bicuspid or unicuspid aortic valves.
Atherosclerosis.
Previous aortic aneurysm repair.
Síndrome de Turner - may be a risk factor.
Cocaine.
Thoracic aortic aneurysm symptoms (Presentation)2 4
Volver al contenidoMost TAAs are asymptomatic (about 95%). They may only be diagnosed incidentally, or if complicated by dissection, rupture, or other complications. Possible presentations are:
Pain - located in the chest, neck, upper back, mid-back or epigastrium - the site may relate to which section of aorta is involved:
Acute or increasing pain suggests expansion, with the risk of impending rupture or dissection.
Acute aortic dissection presents with sudden onset, very severe, tearing or sharp pain which is maximal at the time of onset (in contrast to the more dull, crescendo pain of myocardial infarction).4
Aortic regurgitation - if a proximal TAA involves the aortic valve.
Systemic symptoms (eg, fever) - if there is an infective cause.
Thrombo-embolic presentations:
Arterial emboli.
Disseminated intravascular coagulation - eg, bruising, petechiae.
Symptoms due to compression of local structures:
Hoarseness (recurrent laryngeal nerve).
Cough, stridor, or dyspnoea.
Superior vena cava obstruction.
Disfagia.
Back pain (vertebral body erosion).
Acute aortic dissection12
This may present with:
Severe, sharp pain in the chest, neck or back. The pain may migrate as the dissection progresses.
Ischaemia in the territory of any affected artery - eg, myocardial infarction, neurological features, visceral or limb ischaemia.
Unequal upper limb pulses.
The dissection may progress to rupture.
Ruptured TAA
This may present with:
Acute pain - in the chest, neck or back.
Collapse, shock or sudden death.
If the aneurysm erodes into a nearby structure, there may be:
Haematemesis (aorto-oesophageal fistula).
Haemoptysis (aorto-bronchial fistula).
Hemotórax.
Cardiac tamponade (ruptures into the pericardium).
An acute left to right shunt (aortopulmonary artery fistula).15
Continúa leyendo abajo
Diagnóstico diferencial
Volver al contenidoThis is wide, and TAAs are easily missed or mis-diagnosed. Differential diagnoses include other causes of chest pain, thoracic back pain, arterial ischaemia or collapse.
With acute chest pain, myocardial infarction4 and pulmonary embolus16 are important to differentiate, as these require thrombolysis or anticoagulation, which is contra-indicated for TAA.
Investigaciones14
Volver al contenidoUrgent scenario
For an acutely ill patient with suspected thoracic aortic rupture or dissection, the most relevant investigations are:
Blood tests - FBC, clotting screen, renal and liver function and cross-match.
ECG.
CT scan with contrast.
Magnetic resonance angiography will also provide good images but probably only for stable patients.3
Non-acute scenario
Investigations aim to evaluate the detailed anatomy of the aneurysm, any treatable causes and the patient's fitness for surgery:
Blood tests:
FBC, clotting screen, renal function.
ESR and/or CRP if an inflammatory cause is suspected.
LFTs and amylase, if embolisation or dissection is suspected.
Investigate for a suspected cause, if relevant - eg, syphilis or HIV serology, connective tissue disease.
ECG.
Pruebas de función pulmonar.
Ultrasonido:
Transthoracic echocardiogram shows aortic valve and aortic root.
Transoesophageal echocardiogram shows from the aortic valve to the proximal descending aorta.
Abdominal ultrasound - to look for associated abdominal aneurysms.
Scans:
CT scan with contrast medium is the most widely used diagnostic tool. This defines the precise anatomy and can show the aneurysm, dissection, thrombus or haematoma. Detailed views are needed for endovascular repair planning.
CT angiography is possible and non-invasive, although the contrast material is nephrotoxic.
Magnetic resonance imaging (MRI) also shows the anatomy well; the advantage is that magnetic resonance angiography is not nephrotoxic.
Coronary angiography may be appropriate when assessing fitness for surgery or the possible need for coronary artery bypass grafting (CABG) in addition to aortic surgery.
Thoracic aortic aneurysm treatment and management5 14
Volver al contenidoVea también el separado Ruptured Aortic Aneurysm y Aortic Dissection articles.
Thoracic aneurysms have been managed with treatment with β-blockers and routine surveillance imaging, followed by surgical repair of the aneurysm when the risk of dissection exceeds the risk for repair. Therefore, there is a window to initiate therapies to slow aortic enlargement and delay or ideally prevent the need for surgical repair of the aneurysm to prevent a dissection.
Angiotensin II antagonism preventing aneurysm enlargement was generally viewed as groundbreaking but several large randomised trials involving patients with Marfan syndrome have subsequently yielded no evidence that losartan slows aortic enlargement more effectively than conventional treatment with β-blockers.
Who needs surgery?4
Immediate/urgent surgery is needed for:
Ruptured TAA.
Some types of aortic dissection.
Acute symptoms (because these suggest expansion and impending rupture/dissection).
Symptomatic TAAs merit surgery regardless of their size (because there is a higher risk that they will rupture or dissect).
Asymptomatic TAAs are assessed to evaluate the relative risks/benefits of surgery. The risk of rupture depends on:
Aneurysm diameter. This is the most important factor predicting rupture. The threshold for repair will depend on the individual patient, eg, underlying cause, comorbidities.
Using body surface area as well as aneurysm diameter gives a more accurate risk profile.
Patients with Marfan's syndrome or a strong family history of TAA merit surgery earlier (at a smaller aneurysm diameter).
The rate of expansion is also important.
Manejo médico
Regular monitoring of the aneurysm - eg, by CT or MRI scans every six months.
Rigorous blood pressure control with use of beta-blockers to reduce shear stress across the aortic wall.
Smoking cessation.
Treating the underlying cause where feasible - eg, infection.
Treating other cardiovascular risk factors - eg, hyperlipidaemia.
Conducción
There are Driver and Vehicle Licensing Agency (DVLA) restrictions for aneurysms above a certain size, and requirements for notification.17
Surgical repair
This involves thoracotomy to replace the diseased aorta with a Dacron® graft.
Replacement of the aortic root ± the aortic valve may also be necessary.
There are significant perioperative mortality and complication rates (see 'Prognosis', below).
Endovascular repair1
Endovascular repair is also known as 'endovascular stenting', EVAR (= endovascular aneurysm/aortic repair) or TEVAR (= thoracic endovascular aneurysm/aortic repair). It is a minimally invasive technique which is relatively new. It delivers a stent via a remote vessel.
Reports from non-randomised studies suggest that endovascular repair may improve early outcomes, with reduced mortality and paraplegia rates.
However, TEVAR can have additional complications, ie endoleaks, stent fractures, stent graft migration, iliac artery rupture, retrograde dissection and aorto-oesophageal fistula. These may require re-intervention.
Patients receiving stents require frequent follow-up with CT scans.
Pronóstico1
Volver al contenidoNatural history:
The size of the TAA is the major factor predicting rupture.
The natural course is for the aneurysm to increase in size slowly.
The five-year mortality rate of TAAs >6 cm is 38-64%.
Thoracic aortic aneurysms that progress to acute aortic dissections are often fatal.14
When rupture occurs, patients mostly die within six hours. Although about half arrive alive at the hospital, the overall mortality from ruptured TAAs is up to 97%.
With elective surgical repair:
Perioperative 30-day mortality is 4.8% with open surgery.
Possible complications particular to aortic repair are:
Paraplegia due to spinal cord ischaemia - with descending aorta repairs.
Stroke.
Lesión renal aguda.
A more detailed review of outcomes after surgery is available.
Prevention and screening
Volver al contenidoFor athletes - one expert advises routine screening of all athletes involved in weightlifting or heavy athletics.4
For patients with Marfan's syndrome or Ehlers-Danlos syndrome - lifelong beta-blockers, moderate restriction of physical activity and regular imaging of the aorta.
For patients with a bicuspid aortic valve, assessment of the ascending aorta may be advisable.18
Exclusive updates for healthcare professionals
Stay informed with the latest clinical updates, professional insights, and evidence-based guidance. The Patient Pro newsletter curates essential content for healthcare professionals—delivered straight to your inbox.
By subscribing you accept our Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.
Lecturas adicionales y referencias
- Lu H, Daugherty A; Aortic Aneurysms. Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):e59-e65. doi: 10.1161/ATVBAHA.117.309578.
- Czerny M, Schmidli J, Adler S, et al; Editor's Choice - Current Options and Recommendations for the Treatment of Thoracic Aortic Pathologies Involving the Aortic Arch: An Expert Consensus Document of the European Association for Cardio-Thoracic Surgery (EACTS) & the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2019 Feb;57(2):165-198. doi: 10.1016/j.ejvs.2018.09.016. Epub 2018 Oct 12.
- Abraha I, Romagnoli C, Montedori A, et al; Thoracic stent graft versus surgery for thoracic aneurysm. Cochrane Database Syst Rev. 2016 Jun 6;(6):CD006796. doi: 10.1002/14651858.CD006796.pub4.
- Akin I, Nienaber CA; Interventional treatment strategies of thoracic aortic pathologies. Eur Rev Med Pharmacol Sci. 2014;18(17):2562-74.
- Booher AM, Eagle KA; Diagnosis and management issues in thoracic aortic aneurysm. Am Heart J. 2011 Jul;162(1):38-46.e1. Epub 2011 Jun 15.
- Elefteriades JA; Thoracic aortic aneurysm: reading the enemy's playbook. Yale J Biol Med. 2008 Dec;81(4):175-86.
- Isselbacher EM, Preventza O, Hamilton Black Iii J, et al; 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 Dec 13;80(24):e223-e393. doi: 10.1016/j.jacc.2022.08.004. Epub 2022 Nov 2.
- Aortic Aneurysm, Familial Thoracic 1, AAT1; Herencia Mendeliana en Línea en el Hombre (OMIM)
- Aortic Aneurysm, Familial Thoracic 2, AAT2; Herencia Mendeliana en Línea en el Hombre (OMIM)
- Loeys-Dietz Syndrome, Type 1A, LDS1A; Herencia Mendeliana en Línea en el Hombre (OMIM)
- Kan CD, Lee HL, Yang YJ; Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007 Nov;46(5):906-12. Epub 2007 Oct 1.
- Tilson MD 3rd, Withers L; Arterial aneurysms in HIV patients: molecular mimicry versus direct infection? Ann N Y Acad Sci. 2006 Nov;1085:387-91.
- Manufacturer's PIL, Betnesol® Tablets; UCB Pharma Limited, electronic Medicines Compendium. Dated January 2008, accessed February 2010.
- Thrumurthy SG, Karthikesalingam A, Patterson BO, et al; El diagnóstico y manejo de la disección aórtica. BMJ. 2011 Ene 11;344:d8290. doi: 10.1136/bmj.d8290.
- Zhou Z, Cecchi AC, Prakash SK, et al; Risk Factors for Thoracic Aortic Dissection. Genes (Basel). 2022 Oct 7;13(10):1814. doi: 10.3390/genes13101814.
- Milewicz DM, Ramirez F; Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections. Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):126-136. doi: 10.1161/ATVBAHA.118.310956.
- Modi SA, Raza U, Chang S; A case report of thoracic aneurysm with aortopulmonary artery fistula. Eur J Echocardiogr. 2009 Jan 5.
- Warburton MS, Jackson MA, Norton R, et al; Rare causes of haemoptysis in suspected pulmonary embolism. BMJ. 2004 Sep 4;329(7465):557-8.
- Evaluación de la aptitud para conducir: guía para profesionales médicos; Agencia de Licencias de Conducir y Vehículos
- Cecconi M, Nistri S, Quarti A, et al; Aortic dilatation in patients with bicuspid aortic valve. J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):11-20.
Continúa leyendo abajo
About the authorView full bio

Dr Colin Tidy, MRCGP
Médico General, Autor Médico
MBBS, MRCGP, MRCP (Paediatrics), DCH
Dr Colin Tidy is an NHS Doctor, based in Oxfordshire.
About the reviewerView full bio

Dr Doug McKechnie, MRCGP
Medical Writer
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
Dr Doug McKechnie is an NHS GP working in London. He works full-time clinically and is also the Deputy Lead for the Clinical and Professional Practice module at University College London Medical School.
Historial del artículo
La información en esta página está escrita y revisada por pares por clínicos calificados.
Próxima revisión: 12 de mayo de 2028
12 Jun 2023 | Última versión

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita